COVID-19 vaccines work well in preventing people from being admitted to hospital or ICU for COVID-19, according to a new analysis by RIVM.

Vaccination against COVID-19 reduces the transmission of the virus from one person to another. This is apparent from RIVM research using data from source and contact tracing by the Municipal Public Health Services (GGDs).

The RIVM vaccination update this week has been expanded to include three maps of the Netherlands. For the first time, it is now possible to see vaccination turnout by municipality for everyone aged 18 years and over.

Starting next week, eligible people who are not mobile enough to come to a vaccination site will be vaccinated at home. The GP will vaccinate them using the AstraZeneca vaccine. The vaccines will be delivered in phases per province.

More nitrogen and phosphorus have been ending up in the soil on farms since 2015. As a result, nitrate concentrations have been rising since 2017 in leachates and ditch water from those farms.

The Ministry of Health, Welfare and Sport (VWS) has decided to resume vaccinating with the COVID-19 vaccine made by AstraZeneca within the near future.

The downward trend in infections among nursing home residents in the Netherlands is continuing.

Five groups of patients with specific medical risks will receive an invitation for COVID-19 vaccination this week or next week. It involves four groups of patients with impaired immune systems.

The Ministry of Health, Welfare and Sport (VWS) has decided to temporarily stop vaccinating with the COVID-19 vaccine made by AstraZeneca, effective immediately.

Starting tomorrow, the first people in the age group from 75-79 years will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in the years from 1941 through 1946.